Navigation Links
Telik Announces Revised Date for Year-End Financial Release, Conference Call and Webcast
Date:2/19/2008

PALO ALTO, Calif., Feb. 19 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaq: TELK) announced that its year-end conference call and webcast will be held on Wednesday, February 27, 2008 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) following the release earlier that day of the company's financial results for the fourth quarter and year ended December 31, 2007.

The conference call will be accessible via Telik's website at http://www.telik.com or by telephone at 800-398-9398 or 612-332-0530. An archive of the conference call will be available on the Telik website or by telephone at 800-475-6701 or 320-365-3844, access code 910785. The archive will be available from approximately 6:30 p.m. Eastern time on February 27 through March 12, 2008.

Telik, Inc. of Palo Alto, CA is a biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. The company's most advanced drug development candidates are TELCYTA(R), a tumor-activated small molecule product candidate in clinical development for the treatment of advanced ovarian cancer and non-small cell lung cancer; and TELINTRA(R), which is in clinical development for the treatment of myelodysplastic syndrome. Telik's product candidates were discovered using its proprietary drug discovery technology, TRAP(TM), which enables the rapid and efficient discovery of small molecule drug candidates.


'/>"/>
SOURCE Telik, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Telik Announces Year-End Financial Release, Conference Call and Webcast
2. Telik Announces Presentation and Webcast at JPMorgan Healthcare Conference
3. Telik Announces Presentation and Webcast at UBS Global Life Sciences Conference
4. Telik Announces Presentation and Webcast at Bear Stearns Healthcare Conference
5. 3SBio Inc. Announces Change to the Board of Directors
6. Graceway Pharmaceuticals, LLC(TM) Announces Completed Acquisition of All Assets Related to Estrasorb(R) Product Line in North America From Allergan, Inc. (NYSE: AGN) and Novavax, Inc. (Nasdaq: NVAX)
7. MichBio Announces Annual Meeting Keynote and Pre-Meeting Workshop
8. Cadient Group Announces Recent Executive Promotions
9. Pharmion Corporation Announces 2007 Operating Results
10. Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide an Update on Nexavar and Report Full Year 2007 Financial Results
11. Advanced Life Sciences Announces Fourth Quarter and Full Year 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2014)... Bioquell, provider of germ-eliminating robots ... facilities around the world to decontaminate locations where ... the many places the hydrogen peroxide vapor technology ... Dallas and at the National Institutes of Health ... been utilized to decontaminate patient rooms, equipment, and ...
(Date:10/17/2014)... The North American Knowledge-based/Evidence-based Clinical Decision Support ... market in North America with analysis and forecast ... America is expected to reach around $283.3 million ... from 2013 to 2018. , Browse through the ... support system (CDSS) market, to get an idea ...
(Date:10/17/2014)... October 17, 2014 The report “Feed ... by Livestock (Swine, Cattle, Poultry, Aquatic Animals & Others), ... defines and segments the global feed antioxidant market with ... terms of value for the feed antioxidants. , The ... was estimated to be worth around $191.1 million in ...
(Date:10/17/2014)... October 17, 2014 According ... by Solutions (System Management, Parallel Environment, and ... and Licenses), by Platforms (Windows, Linux and ... - Global Forecast to 2019", by MarketsandMarkets, ... of the overall market, segmented by solutions, ...
Breaking Biology Technology:Bioquell’s Vapor Producing Robots Selected to Combat Ebola in Hospitals Around the World 2Bioquell’s Vapor Producing Robots Selected to Combat Ebola in Hospitals Around the World 3Bioquell’s Vapor Producing Robots Selected to Combat Ebola in Hospitals Around the World 4Bioquell’s Vapor Producing Robots Selected to Combat Ebola in Hospitals Around the World 5Bioquell’s Vapor Producing Robots Selected to Combat Ebola in Hospitals Around the World 6The North American Knowledge-based/Evidence-based Clinical Decision Support System (CDSS) market is expected to reach around $283.3 million by 2018 - MicroMarket Monitor 2The North American Knowledge-based/Evidence-based Clinical Decision Support System (CDSS) market is expected to reach around $283.3 million by 2018 - MicroMarket Monitor 3The North American Knowledge-based/Evidence-based Clinical Decision Support System (CDSS) market is expected to reach around $283.3 million by 2018 - MicroMarket Monitor 4The North American Knowledge-based/Evidence-based Clinical Decision Support System (CDSS) market is expected to reach around $283.3 million by 2018 - MicroMarket Monitor 5Feed Antioxidants Market Projected To Reach $238.5 Million by 2018 - New Report by MarketsandMarkets 2Feed Antioxidants Market Projected To Reach $238.5 Million by 2018 - New Report by MarketsandMarkets 3Feed Antioxidants Market Projected To Reach $238.5 Million by 2018 - New Report by MarketsandMarkets 4Clustering Software Market worth $2,940.8 Million in 2019 - New Report by MarketsandMarkets 2Clustering Software Market worth $2,940.8 Million in 2019 - New Report by MarketsandMarkets 3Clustering Software Market worth $2,940.8 Million in 2019 - New Report by MarketsandMarkets 4
... Neb., Nov. 6 Transgenomic (OTC,Bulletin Board: TBIO) today announced ... the Rodman & Renshaw 10th Annual,Healthcare Conference to be held ... York City. Mr. Tuttle and Debra Schneider, Chief,Financial Officer, will ... Event: Rodman & Renshaw 10th Annual ...
... researchers are showing that Microsoft SQL ... up to 1 petabyte., REDMOND, Wash., Nov. ... its data management and business,intelligence platform, Microsoft SQL ... software to scale new heights in data warehousing,and ...
... AHCC for cancer patients undergoing chemotherapy, PURCHASE, ... in,the Journal of the Society for Integrative Oncology ... researchers at the University of Texas M.D.,Anderson Cancer ... Up,Chemical Company in Sapporo, Japan has demonstrated that ...
Cached Biology Technology:Transgenomic to Present at Rodman & Renshaw 10th Annual Healthcare Conference 2Could Database Software Help Cure Alzheimer's and Save the Earth? 2Could Database Software Help Cure Alzheimer's and Save the Earth? 3Study From the University of Texas M.D. Anderson Cancer Center Demonstrates That AHCC(R) is Safe in Combination With Most Chemotherapeutic Agents 2Study From the University of Texas M.D. Anderson Cancer Center Demonstrates That AHCC(R) is Safe in Combination With Most Chemotherapeutic Agents 3
(Date:10/15/2014)... Gauß-Allianz has admitted Johannes Gutenberg University Mainz (JGU) ... science hub continues to maintain a significant nationwide ... , "The acceptance of Johannes Gutenberg University Mainz ... a milestone in the national and international competition ... state of Rhineland-Palatinate can be proud that Mainz ...
(Date:10/15/2014)... , Oct. 15, 2014   Neurotechnology ... today announced the availability of the VeriLook ... Surveillance 3.0 provides real-time biometric face identification using ... digital surveillance cameras. The new version not only ... differentiates people from objects while they are moving ...
(Date:10/14/2014)... One of the planet,s leading questions is how to ... increasingly variable climate. The Food and Agriculture Organization of ... 70% over the next 40 years to feed a ... of the necessary rise in food production. Plants—grains, ... by supporting livestock. Current research must tap into ...
Breaking Biology News(10 mins):Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 2Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 3VeriLook Surveillance 3.0 SDK Identifies Faces and Moving Objects, Differentiates Pedestrians from Other Moving Objects in Video Surveillance Systems 2VeriLook Surveillance 3.0 SDK Identifies Faces and Moving Objects, Differentiates Pedestrians from Other Moving Objects in Video Surveillance Systems 3Building a bridge from basic botany to applied agriculture 2Building a bridge from basic botany to applied agriculture 3
... research team coordinated at the IRCM in Montral found ... Dr. Tarik Mry, the IRCM,s President and Scientific Director, ... "Achilles, heel" and could be targeted to develop a ... current treatments such as chemotherapy and radiation therapy. The ...
... common element but is found in old paints (including ... water, and the atmosphere from lead-containing vehicular fuels, even ... also causes seemingly trivial symptoms such as headaches. However, ... to the organs, the kidneys in particular, and the ...
... prostate cancer is the most common cancer in elderly ... aged between 35 and 50. Scientists at the European ... with several other research teams in Germany*, have discovered ... different mechanism from that which causes the disease at ...
Cached Biology News:Researchers discover 'Achilles' heel' for lymphoid leukemia 2Is lead poisoning behind some juvenile crime? 21 disease, 2 mechanisms 2
Human peripheral blood eosinophils, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Granulocytes...
Monocyte-derived dendritic cells, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood Dendritic Cells...
Umbilical cord blood CD14+ Monocytes, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood Monocytes, B Cells and NK Cells...
Umbilical cord blood CD19+ B cells, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood Monocytes, B Cells and NK Cells...
Biology Products: